BriaCell Therapeutics Corp. (BCTX )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol BCTX
- Company BriaCell Therapeutics Corp.
- Price $4.22
- Changes Percentage 18.54
- Change 0.66
- Day Low $3.61
- Day High $4.35
- Year High $14.68
- Year Low $2.6
- Market Cap $35,408,145
- Price Avg 50 EMA (D) $3.43
- Price Avg 200 EMA (D) $5.12
- Exchange NASDAQ
- Volume 147,919
- Average Volume 158,758
- Open $3.69
- Previous Close $3.56
- EPS -18.41
- PE -0.22
- Earnings Announcement 2026-06-09 20:06:01
- Shares Outstanding $8,699,790
Company brief: BRIACELL THERAPEUTICS CORP. (BCTX )
- Healthcare
- Biotechnology
- Dr. William V. Williams M.D.
- https://www.briacell.com
- CA
- N/A
- 03-14-2012
- CA1079301091
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.